Phase 2 IPF Study Now Enrolling Learn More »
Phase 2 SSc Study Now Enrolling Learn More »

Our Mission

Fearlessly pioneering novel therapies to make meaningful impact and provide hope for patients with fibrotic diseases.


Michael Choi, MD LinkedIn for Michael Choi, MD

Bryan Fuchs, PhD LinkedIn for Bryan Fuchs, PhD

David Lagares, PhD LinkedIn for David Lagares, PhD

Shelia Violette, PhD LinkedIn for Shelia Violette, PhD

Thomas Wynn, PhD LinkedIn for Thomas Wynn, PhD